No images? Click here

 
WebsiteLinkedInTwitterYouTube
 
 

Biopharma Adaptive Trials on THREAD Now Enrolling

 
Read the Full Announcement >
 

Several new global adaptive clinical studies designed with THREAD have launched and are actively enrolling patients today.

Since announcing the solution earlier this year, sponsors and CROs have used THREAD’s configurable, no-code platform to support Phase Ib–IV trials and registries with complex cohorts, treatment arms, participant pathways, and protocol adaptations.

THREAD helps research teams by providing:

  • Configurable participant pathways across multiple cohorts and treatment arms

  • Rapid implementation of protocol adaptations

  • Role-based governance for participant transitions

  • Automated visits, tasks, and participant workflows

  • A single study configuration that can evolve with the trial

As regulatory initiatives continue to support more efficient approaches to evidence generation, adaptive trial designs offer sponsors additional flexibility to optimize enrollment, resources, and study execution while maintaining rigorous scientific standards.

Read the latest announcement and learn how THREAD can support your next adaptive clinical trial. Read the announcement

 
 
 
 
 
 

THREAD® provides a fully configurable clinical research platform to enable studies for everyone, everywhere. Through its industry-leading technology and scientific expertise, we empower studies to be more accessible, efficient, and patient-centered.

 
 
Request a Quick Demo
Watch Our Platform Video
 
 
 
 

Connect With Us

LinkedInTwitterYouTube
 

THREAD Newsletter Subscription

Unsubscribe